Department of Neurosurgery, Nanoori Suwon Hospital, Suwon, Republic of Korea.
Department of Neurosurgery, Hasan Sadikin Hospital, College of Medicine, Padjadjaran University, Bandung, Jawa Barat, Indonesia.
Biomed Res Int. 2018 Jan 18;2018:5349680. doi: 10.1155/2018/5349680. eCollection 2018.
To evaluate the efficacy of suprapedicular circumferential opening technique (SCOT) of percutaneous endoscopic transforaminal lumbar discectomy (PETLD) for high grade inferiorly migrated lumbar disc herniation.
Eighteen consecutive patients who presented with back and leg pain with a single-level high grade inferiorly migrated lumbar disc herniation were included. High grade inferiorly migrated disc was removed by the SCOT through PETLD approach. Outcome evaluation was done with visual analog scale (VAS) and Mac Nab's criteria.
There were 14 males and 4 females. The mean age of patients was 53.3 ± 14.12 years. One, 4, and 13 patients had disc herniation at L1-2, L3-4, and L4-5 levels, respectively, on MRI, which correlated with clinical findings. The mean follow-up duration was 8.4 ± 4.31 months. According to Mac Nab's criteria, 9 patients (50%) reported excellent and the remaining 9 patients (50%) reported good outcomes. The mean preoperative and postoperative VAS for leg pain were 7.36 ± 0.73 and 1.45 ± 0.60, respectively ( < 0.001). Improvement in outcomes was maintained even at final follow-up. There was no complication.
In this preliminary study we achieved good to excellent clinical results using the SCOT of PETLD for high grade inferiorly migrated lumbar disc herniation.
评估经皮椎间孔内窥镜腰椎间盘切除术(PETLD)中经椎弓根周围环形开窗技术(SCOT)治疗高位向下移位型腰椎间盘突出症的疗效。
纳入 18 例因单节段高位向下移位型腰椎间盘突出症而出现腰背腿痛的患者。通过 PETLD 入路,采用 SCOT 切除高位向下移位的椎间盘。采用视觉模拟评分(VAS)和 Mac Nab 标准进行疗效评估。
患者中男 14 例,女 4 例;平均年龄为 53.3 ± 14.12 岁。MRI 显示 1 例、4 例和 13 例患者 L1-2、L3-4 和 L4-5 水平分别存在椎间盘突出,与临床发现相符。平均随访时间为 8.4 ± 4.31 个月。根据 Mac Nab 标准,9 例(50%)患者报告为优,9 例(50%)患者报告为良。术前和术后腿痛的平均 VAS 分别为 7.36 ± 0.73 和 1.45 ± 0.60(<0.001)。即使在最终随访时,疗效仍得到保持。无并发症发生。
在这项初步研究中,我们使用 PETLD 中的 SCOT 治疗高位向下移位型腰椎间盘突出症,取得了良好至优秀的临床效果。